Providing Verju laser treatments is in keeping with the philosophy of care at the Urogynecology Arts of New Jersey, where women's needs are met though innovation, safety and evidence-based practices.
East Brunswick, NJ (PRWEB) March 03, 2014
Erchonia's Verjú laser is the newest and most exciting addition to the innovative care offered by Dr. Mark L. Mokrzycki and Joan Zaccardi DrNP, at the Urogynecology Arts of New Jersey. The FDA-approved, completely noninvasive Verjú laser significantly reduces the appearance of cellulite on the thighs, buttocks and lower abdomen in just two weeks.
Dr. Mokrzycki comments, “Providing Verjú laser treatments is in keeping with the philosophy of care at the Urogynecology Arts of New Jersey, where women's needs are met though innovation, safety and evidence-based practices.”
Erchonia’s Verjú laser system is made up of five low level laser beams that sweep the area of concern for a total treatment period of 30 minutes. Without incisions, pain or even heat, the low level laser emulsifies tissue beneath the skin to reduce the appearance of cellulite. Patients can continue their daily routines immediately following treatment, and there is no downtime or pain whatsoever.
For more information or to book a Verjú consultation at the Urogynecology Arts of New Jersey, please visit http://www.uartsnj.com or call (732) 651-0005.
Erchonia is the global leader in low level laser healthcare applications. Over the last 15 years Erchonia has been conducting research and development with the world’s leading physicians to advance the science of low level lasers. Prior to market introduction, all Erchonia lasers are proven safe and effective through independent clinical trials. Currently thousands of Erchonia’s lasers are used daily to reduce body fat and cellulite, eliminate pain, and treat acne. For additional information, visit http://www.erchonia.com.